Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Corticosteroids for Lumbar Facet Joint Synovitis
NCT04860531Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Sep 2019
- Primary completion
- Jan 2021
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 3, randomised trial of autologous platelet-rich plasma in lumbar facet joint syndrome (LFS) (2 arms), sponsored by Ain Shams University. Primary endpoints: Number of lumbar facet joints showing tenderness on palpation at 3 months, Maximum active lumber extension angle at 3 months and 4 more. Started Sep 2019; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
lumbar facet joint syndrome (LFS)
Beyond the preview
Go deeper on NCT04860531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04860531.